Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aquamin® for Mild Ulcerative Colitis and Ulcerative Colitis in Remission
NCT03869905Phase 2Active, not recruiting
- Start
- Aug 2019
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 2, randomised trial in ulcerative colitis (UC) comparing Aquamin® with Placebo first then Aquamin® (2 arms). Primary endpoints: Inflammatory Bowel Disease Questionnaire at 180 days, Ulcerative Colitis Disease Activity Index / Mayo Scoring at 180 days and 3 more. Started Aug 2019; status: active, not recruiting.
02
Drugs
Lithothamnion calcareum extract
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT03869905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03869905.